Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 655,847 | 724,343 | 770,885 | 842,681 | 821,682 |
| Cost of Goods | 331,279 | 359,889 | 408,519 | 435,668 | 415,335 |
| Gross Profit | 324,568 | 364,454 | 362,366 | 407,013 | 406,347 |
| Operating Expenses | 352,834 | 258,051 | 450,708 | 491,976 | 624,033 |
| Operating Income | -27,987 | 107,292 | -87,823 | -84,295 | -217,351 |
| Interest Expense | 56,280 | 54,601 | 60,819 | 57,837 | 51,211 |
| Other Income | -11,155 | -63,307 | 1,740 | 15,227 | 11,835 |
| Pre-tax Income | -95,422 | -10,616 | -146,902 | -126,905 | -256,727 |
| Income Tax | 44,622 | 49,873 | 32,950 | 88,938 | 40,107 |
| Net Income Continuous | -140,044 | -60,489 | -179,852 | -215,843 | -296,834 |
| Minority Interests | -4,636 | 13,949 | -4,330 | -3,796 | 22,763 |
| Net Income | $-135,408 | $-74,438 | $-175,522 | $-212,047 | $-319,597 |
| EPS Basic Total Ops | -0.38 | -0.22 | -0.54 | -0.71 | -1.22 |
| EPS Basic Continuous Ops | -0.39 | -0.18 | -0.56 | -0.72 | -1.13 |
| EPS Diluted Total Ops | -0.38 | -0.22 | -0.54 | -0.71 | -1.22 |
| EPS Diluted Continuous Ops | -0.39 | -0.18 | -0.56 | -0.72 | -1.13 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.22 | -0.17 | -0.20 | -0.05 |
| EBITDA(a) | $27,752 | $173,285 | $-18,519 | $-26,570 | $-172,402 |